MX9304266A - Quinolinas y naftiridinas de 3-carboxaldehido sustituidas. - Google Patents
Quinolinas y naftiridinas de 3-carboxaldehido sustituidas.Info
- Publication number
- MX9304266A MX9304266A MX9304266A MX9304266A MX9304266A MX 9304266 A MX9304266 A MX 9304266A MX 9304266 A MX9304266 A MX 9304266A MX 9304266 A MX9304266 A MX 9304266A MX 9304266 A MX9304266 A MX 9304266A
- Authority
- MX
- Mexico
- Prior art keywords
- naftiridines
- carboxaldehido
- quinolins
- substituted
- prodrugs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Esta invención se refiere a profármacos de quinolina y naftiridina que tienen un grupo 3-carboxaldehído, a composiciones antibacterianas que contienen dichos profármacos y a un método para tratar infecciones bacterianas administrando dichos profármacos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/914,188 US5235054A (en) | 1992-07-15 | 1992-07-15 | 3-carboxaldehyde substituted quinolines and naphthyridines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9304266A true MX9304266A (es) | 1994-01-31 |
Family
ID=25434020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9304266A MX9304266A (es) | 1992-07-15 | 1993-07-14 | Quinolinas y naftiridinas de 3-carboxaldehido sustituidas. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5235054A (es) |
| EP (1) | EP0650488A1 (es) |
| JP (1) | JPH07504684A (es) |
| KR (1) | KR950702561A (es) |
| CN (1) | CN1083053A (es) |
| AU (1) | AU669958B2 (es) |
| BR (1) | BR9306733A (es) |
| CA (1) | CA2140135A1 (es) |
| CZ (1) | CZ280603B6 (es) |
| FI (1) | FI933203A (es) |
| HU (1) | HUT68745A (es) |
| IL (1) | IL106264A0 (es) |
| MX (1) | MX9304266A (es) |
| NO (1) | NO950142L (es) |
| NZ (1) | NZ252847A (es) |
| PL (1) | PL307135A1 (es) |
| RU (1) | RU2097379C1 (es) |
| SK (1) | SK4695A3 (es) |
| WO (1) | WO1994002480A1 (es) |
| ZA (1) | ZA935076B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378694A (en) * | 1990-09-07 | 1995-01-03 | Schering Corporation | Acyl and alkoxy substituted quinolines |
| EP0868183B1 (en) * | 1995-12-21 | 2002-01-30 | Pfizer Inc. | Injectable quinolone formulations |
| JO3077B1 (ar) * | 2005-07-28 | 2017-03-15 | Janssen Pharmaceutica Nv | مشتقات كوينولين مضادة للبكتيريا |
| EP2429991B1 (en) | 2009-05-15 | 2014-09-10 | Redx Pharma Limited | Redox drug derivatives |
| WO2020184578A1 (ja) * | 2019-03-11 | 2020-09-17 | 小胞体ストレス研究所株式会社 | 新規なｅＩＦ２αのリン酸化促進剤 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2509728A1 (fr) * | 1981-07-17 | 1983-01-21 | Roussel Uclaf | Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant |
| IN166416B (es) * | 1985-09-18 | 1990-05-05 | Pfizer | |
| JP2777661B2 (ja) * | 1988-10-20 | 1998-07-23 | 大塚製薬株式会社 | ベンゾヘテロ環化合物 |
-
1992
- 1992-07-15 US US07/914,188 patent/US5235054A/en not_active Expired - Lifetime
-
1993
- 1993-04-23 WO PCT/US1993/003624 patent/WO1994002480A1/en not_active Application Discontinuation
- 1993-04-23 RU RU9595105159A patent/RU2097379C1/ru active
- 1993-04-23 JP JP6503987A patent/JPH07504684A/ja active Pending
- 1993-04-23 NZ NZ252847A patent/NZ252847A/en unknown
- 1993-04-23 EP EP93912293A patent/EP0650488A1/en not_active Withdrawn
- 1993-04-23 CA CA002140135A patent/CA2140135A1/en not_active Abandoned
- 1993-04-23 CZ CZ95101A patent/CZ280603B6/cs unknown
- 1993-04-23 BR BR9306733A patent/BR9306733A/pt not_active Application Discontinuation
- 1993-04-23 SK SK46-95A patent/SK4695A3/sk unknown
- 1993-04-23 AU AU55746/94A patent/AU669958B2/en not_active Ceased
- 1993-04-23 KR KR1019950700158A patent/KR950702561A/ko not_active Application Discontinuation
- 1993-04-23 PL PL93307135A patent/PL307135A1/xx unknown
- 1993-07-07 IL IL106264A patent/IL106264A0/xx unknown
- 1993-07-14 MX MX9304266A patent/MX9304266A/es not_active Application Discontinuation
- 1993-07-14 HU HU9302018A patent/HUT68745A/hu unknown
- 1993-07-14 ZA ZA935076A patent/ZA935076B/xx unknown
- 1993-07-14 CN CN93108457A patent/CN1083053A/zh active Pending
- 1993-07-14 FI FI933203A patent/FI933203A/fi unknown
-
1995
- 1995-01-13 NO NO950142A patent/NO950142L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL307135A1 (en) | 1995-05-02 |
| KR950702561A (ko) | 1995-07-29 |
| HUT68745A (en) | 1995-07-28 |
| NZ252847A (en) | 1996-07-26 |
| WO1994002480A1 (en) | 1994-02-03 |
| FI933203A0 (fi) | 1993-07-14 |
| NO950142D0 (no) | 1995-01-13 |
| AU669958B2 (en) | 1996-06-27 |
| NO950142L (no) | 1995-01-13 |
| SK4695A3 (en) | 1995-07-11 |
| US5235054A (en) | 1993-08-10 |
| RU2097379C1 (ru) | 1997-11-27 |
| CZ10195A3 (en) | 1995-09-13 |
| CA2140135A1 (en) | 1994-02-03 |
| FI933203A (fi) | 1994-01-16 |
| HU9302018D0 (en) | 1993-10-28 |
| ZA935076B (en) | 1995-01-16 |
| IL106264A0 (en) | 1993-11-15 |
| EP0650488A1 (en) | 1995-05-03 |
| RU95105159A (ru) | 1997-02-10 |
| JPH07504684A (ja) | 1995-05-25 |
| CN1083053A (zh) | 1994-03-02 |
| BR9306733A (pt) | 1999-01-12 |
| AU5574694A (en) | 1994-02-14 |
| CZ280603B6 (cs) | 1996-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199901127T2 (xx) | Antibakteriyel etkili 6-O-ikameli ketolitler. | |
| BR9802851A (pt) | Antibióticos de macrolìdeo substituìdos por c-4 | |
| MX9304638A (es) | Composicion para tratar e inhibir las ulceras gastricas y duodenales. | |
| PT971713E (pt) | Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao | |
| BR9810151A (pt) | Composto, composição farmacêutica e método para tratamento ou prevenção de uma desordem tromoboembólica | |
| UA26213C2 (uk) | Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові | |
| DK1169060T3 (da) | Natriumkanalblokkerpræparater og anvendelse deraf | |
| BR9301245A (pt) | Composicao,isenta de fosfato,para lavagem de loucas em maquina | |
| BR9813319A (pt) | Composto, composição farmacêutica para tratamento de infecções bacterianas, e, processos para tratar infecções bacterianas e para preparar um composto | |
| PA8485601A1 (es) | Azalidas de 13 miembros y su uso como agentes antibioticos. | |
| DK0699439T3 (da) | Behandling af sygdomme forårsaget af talgkirtellidelser med acyl-CoA-cholesterolacyltransferaseinhibitorer | |
| BR9813317A (pt) | Composto, composição farmacêutica para tratar infecções bacterianas, e, processos para tratar infecções bacterianas, e para preparar um composto | |
| MX9304266A (es) | Quinolinas y naftiridinas de 3-carboxaldehido sustituidas. | |
| BR9710957A (pt) | Composição compreendendo um inibidor de canal katp uso no tratamento hemorrágico | |
| MX9708611A (es) | Compuestos de dialquiltiacumicina. | |
| DE69813200D1 (de) | Verbesserung der wundheilung mit cm101/gbs-toxin | |
| DE69717988D1 (de) | Topische verabreichung von premafloxacin zur behandlung von systemischen bakteriellen erkrankungen | |
| DK1007530T3 (da) | 6-O-substituerede erythromycinforbindelser samt fremgangsmåde til fremstilling heraf | |
| WO1990006307A3 (en) | Antibacterial quinolone compounds | |
| BR0008603A (pt) | Método para tratamento de copd | |
| ES2084878T3 (es) | Sal colina de diclofenac, un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. | |
| CY1107038T1 (el) | Μεθοδος θεραπειας βακτηριακων λοιμωξεων με χρηση της γεμιφλοξασινης ή ενος αλατος αυτης και ενος αντιβιοτικου β-λακταμης | |
| PT972521E (pt) | Composicao farmaceutica contendo estimuladores de interferao gama | |
| PT90085A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo um complexo organico de ouro para aplicacao topica | |
| EP1496742A4 (en) | USE OF NON-ANTIBACTERIAL TETRACYCLINE ANALOGUES AND THEIR FORMULATIONS IN THE TREATMENT OF BACTERIAL EXOTOXINS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |